A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction

Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings

Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930 · see citing works

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · see citing works

Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors

Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531 · see citing works

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312 · see citing works

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654 · see citing works

Monitoring the Future national survey results on drug use, 1975-2016: Volume II, college students and adults ages 19-55

Volume, I. I. (2017) · Institute for Social Research eBooks · doi:10.3998/2027.42/139710 · Cited by 1,369 · see citing works

A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders

Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287 · see citing works

Results from the 2003 National Survey on Drug Use and Health: National Findings

(2004) · PsycEXTRA Dataset · doi:10.1037/e400442005-001 · Cited by 1,245 · see citing works

A Medical Treatment for Diacetylmorphine (Heroin) Addiction: A Clinical Trial With Methadone Hydrochloride

Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240 · see citing works

Addictive Drugs and Brain Stimulation Reward

Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792 · see citing works

Organization of endogenous opiate and nonopiate pain control systems

Watkins, L. R., & Mayer, D. J. (1982) · Science · doi:10.1126/science.6281891 · Cited by 791 · see citing works

Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers

Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 737 · see citing works

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation

Connock, M. J., Juarez-Garcia, A., Jowett, S. M., Frew, E. J., Liu, Z., Taylor, R. S., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T. E., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 580 · see citing works

An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research

Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567 · see citing works

Oral naltrexone maintenance treatment for opioid dependence

Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 432 · see citing works

Addiction to opioids in chronic pain patients: A literature review

Højsted, J., & Sjøgren, P. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2006.08.004 · Cited by 424 · see citing works

Role of maintenance treatment in opioid dependence

Ward, J., Hall, W., & Mattick, R. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05356-2 · Cited by 419 · see citing works

Methadone maintenance at different dosages for opioid dependence

Faggiano, F., Vigna‐Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 409 · see citing works

Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review

Farrell, M., Ward, J., Mattick, R. P., Hall, W., Stimson, G. V., Jarlais, D. D., Gossop, M., & Strang, J. (1994) · BMJ · doi:10.1136/bmj.309.6960.997 · Cited by 393 · see citing works

Heroin overdose: causes and consequences

Warner‐Smith, M., Darke, S. G., Lynskey, M. T., & Hall, W. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96811135.x · Cited by 382 · see citing works

Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction

Oviedo‐Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D. P., Anis, A. H., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 371 · see citing works

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub4 · Cited by 369 · see citing works

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial

Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.210 · Cited by 348 · see citing works

There and Back Again: A Tale of Norepinephrine and Drug Addiction

Weinshenker, D., & Schroeder, J. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 347 · see citing works

Heroin Overdose: Research and Evidence-Based Intervention

Darke, S. G. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg022 · Cited by 332 · see citing works

Naltrexone

Gonzalez, J. P., & Brogden, R. N. (1988) · Drugs · doi:10.2165/00003495-198835030-00002 · Cited by 315 · see citing works

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta‐analytical review

Johansson, B. A., Berglund, M., & Lindgren, A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01369.x · Cited by 305 · see citing works

Buprenorphine for the management of opioid withdrawal

Gowing, L., Ali, R., & White, J. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002025.pub4 · Cited by 297 · see citing works

Contingency management in outpatient methadone treatment: a meta-analysis

Griffith, J. D., Rowan‐Szal, G. A., Roark, R. R., & Simpson, D. D. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00068-x · Cited by 291 · see citing works

Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses

Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00227.x · Cited by 284 · see citing works

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety

Noble, M., Tregear, S., Treadwell, J. R., & Schoelles, K. M. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.03.015 · Cited by 274 · see citing works

Alpha2-adrenergic agonists for the management of opioid withdrawal

Gowing, L., Farrell, M., Ali, R. L., & White, J. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub5 · Cited by 272 · see citing works

The economic costs of heroin addiction in the United States

Mark, T. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00162-9 · Cited by 271 · see citing works

Heroin-assisted treatment for opioid dependence

Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M. R., & Naber, D. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026112 · Cited by 264 · see citing works

Efficacy of antidepressants in substance use disorders with and without comorbid depression

Torrens, M., Fonseca, F., Mateu-Codina, G., & Farré, M. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 262 · see citing works

QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial

Wedam, E. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2469 · Cited by 260 · see citing works

Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs

Cunha‐Oliveira, T., Rego, A. C., & Oliveira, C. R. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.03.002 · Cited by 243 · see citing works

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.

Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub4 · Cited by 235 · see citing works

Methadone at tapered doses for the management of opioid withdrawal

Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R. L., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 229 · see citing works

Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence

Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206 · see citing works

Substitution treatment of injecting opioid users for prevention of HIV infection

Gowing, L., Farrell, M., Bornemann, R., & Ali, R. L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub2 · Cited by 204 · see citing works

Polydrug dependence and psychiatric comorbidity among heroin injectors

Darke, S. G., & Ross, J. E. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00117-8 · Cited by 198 · see citing works

Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys

McCabe, S. E., Cranford, J. A., & West, B. T. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.06.005 · Cited by 197 · see citing works

Overdose training and take‐home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses

Strang, J., Manning, V., Mayet, S., Best, D. W., Titherington, E., Santana, L., Offor, E., & Semmler, C. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02314.x · Cited by 197 · see citing works

Are detoxification programmes effective?

Mattick, R. P., & Hall, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90215-9 · Cited by 196 · see citing works

Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA

Wagner, K. D., Valente, T. W., Casanova, M., Partovi, S. M., Mendenhall, B. M., Hundley, J. H., Gonzalez, M., & Unger, J. B. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.01.003 · Cited by 192 · see citing works

Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States

Green, T. C., Heimer, R. R., & Grau, L. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02182.x · Cited by 192 · see citing works

Altered methadone pharmacokinetics in methadone-maintained pregnant women.

Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., & Benowitz, N. L. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21130-2 · Cited by 189 · see citing works

The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.

Cacciola, J., Alterman, A., Rutherford, M., McKay, J. R., & Mulvaney, F. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00148-4 · Cited by 183 · see citing works

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

Farré, M., Mas, A., Torrens, M., Moreno, V. R., & Camı́, J. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00171-5 · Cited by 180 · see citing works

Evidence-Based Treatment of Opioid-Dependent Patients

van den Brink, W., & Haasen, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101003 · Cited by 147 · see citing works

Take‐home naloxone to reduce heroin death

Baca, C. T., & Grant, K. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01259.x · Cited by 137 · see citing works

Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment

Hyman, S. M., Fox, H., Hong, K.-I. A., Doebrick, C., & Sinha, R. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.2.134 · Cited by 133 · see citing works

Assessment and Treatment of Comorbid Psychiatric Disorders in Opioid-Dependent Patients

Strain, E. C. (2002) · Clinical Journal of Pain · doi:10.1097/00002508-200207001-00003 · Cited by 132 · see citing works

Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version® Connect prescription opioid database

Green, T. C., Serrano, J. M. G., Licari, A., Budman, S. H., & Butler, S. F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.014 · Cited by 127 · see citing works

A Primer of Drug Action: A Concise, Nontechnical Guide to the Actions, Uses, and Side Effects of Psychoactive Drugs

Julien, R. M. (1997) · Medical Entomology and Zoology · Cited by 120 · see citing works

Prescription Naloxone: A Novel Approach to Heroin Overdose Prevention

Sporer, K. A., & Kral, A. H. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.05.025 · Cited by 117 · see citing works

Behavioral family counseling and naltrexone for male opioid-dependent patients.

Fals-Stewart, W., & O'Farrell, T. J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.3.432 · Cited by 116 · see citing works

Substitution treatment of injecting opioid users for prevention of HIV infection

Gowing, L., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub3 · Cited by 116 · see citing works

Sustained-Release Naltrexone For Opioid Dependence

Lobmaier, P. P. K., Kornør, H., Kunøe, N., & Bjørndal, A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006140.pub2 · Cited by 109 · see citing works

Alpha2 adrenergic agonists for the management of opioid withdrawal

Gowing, L., Farrell, M., Ali, R. L., & White, J. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub2 · Cited by 107 · see citing works

Naltrexone and buprenorphine combination in the treatment of opioid dependence

Gerra, G., Fantoma, A., & Zaimovic, A. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060835 · Cited by 106 · see citing works

Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy

Avants, S. K., Margolin, A., Usubiaga, M. H., & Doebrick, C. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00159-4 · Cited by 106 · see citing works

Oral naltrexone maintenance treatment for opioid dependence

Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub2 · Cited by 106 · see citing works

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99 · see citing works

Consensus statement on office-based treatment of opioid dependence using buprenorphine

Fiellin, D. A., Kleber, H. D., Trumble, J. G., McLellan, A. T., & Kosten, T. R. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.06.005 · Cited by 96 · see citing works

LAAM maintenance vs methadone maintenance for heroin dependence

Clark, N. C., Lintzeris, N., Gijsbers, A. J., Whelan, G., Dunlop, A. J., Ritter, A. J., & Ling, W. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002210 · Cited by 93 · see citing works

Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness?

Nunes, E. V., Rothenberg, J. L., Sullivan, M. A., Carpenter, K. M., & Kleber, H. D. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990600918973 · Cited by 93 · see citing works

Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia

Krupitsky, E. M., Zvartau, E. E., Masalov, D. V., Tsoy, M. V., Burakov, A. M., Egorova, V. Y., Didenko, T. Y., Romanova, T. N., Ivanova, E. B., Bespalov, A. Y., et al. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.05.005 · Cited by 93 · see citing works

Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder

Subramaniam, G., & Stitzer, M. L. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.10.015 · Cited by 93 · see citing works

Psychiatric Comorbidity: Prevalence in Methadone Maintenance Treatment

Milby, J. B., Sims, M., Khuder, S., Schumacher, J. E., Huggins, N., McLellan, A. T., WOODY, G. E., & Haas, N. (1996) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999609001647 · Cited by 89 · see citing works

Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes

Carroll, K. M. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00038-x · Cited by 85 · see citing works

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal

Gowing, L., Ali, R. L., & White, J. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002022.pub3 · Cited by 84 · see citing works

Differential activation of G‐proteins byμ‐opioid receptor agonists

Saidak, Z., Blake-Palmer, K. G., Hay, D. L., Northup, J. K., & Glass, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706661 · Cited by 81 · see citing works

Delta-Opioid Receptor Antagonists Prevent Sensitization to the Conditioned Rewarding Effects of Morphine

Shippenberg, T. S., Chefer, V. I., & Thompson, A. C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.009 · Cited by 80 · see citing works

Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews

Amato, L., Davoli, M., Ferri, M., Gowing, L., & Perucci, C. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.002 · Cited by 80 · see citing works

Opioid antagonists with minimal sedation for opioid withdrawal

Gowing, L., Ali, R. L., & White, J. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002021.pub4 · Cited by 78 · see citing works

Opioid Antagonists, Partial Agonists, and Agonists/Antagonists: The Role of OfficeBased Detoxification

Helm, S. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/225 · Cited by 78 · see citing works

Methadone at tapered doses for the management of opioid withdrawal

Amato, L., Davoli, M., Minozzi, S., Ali, R. L., & Ferri, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub3 · Cited by 77 · see citing works

Retention in methadone maintenance drug treatment for prescription‐type opioid primary users compared to heroin users

Banta‐Green, C. J., Maynard, C. C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02538.x · Cited by 75 · see citing works

Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine.

Mendelson, J. E., Flower, K., Pletcher, M. J., & Galloway, G. P. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013637 · Cited by 71 · see citing works

Optimizing Long-Term Response to Methadone Maintenance Treatment

Maxwell, S., & Shinderman, M. S. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n03_01 · Cited by 71 · see citing works

Depression of Morphine-seeking Behaviour by Dopamine Inhibition

Schwartz, A. S., & Marchok, P. L. (1974) · Nature · doi:10.1038/248257a0 · Cited by 68 · see citing works

The Treatment of Opioid Dependence

Galanter, M. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1650 · Cited by 66 · see citing works

Pharmacotherapy of Dual Substance Abuse and Dependence

Kenna, G. A., Nielsen, D. M., Mello, P., Schiesl, A., & Swift, R. M. (2007) · CNS Drugs · doi:10.2165/00023210-200721030-00003 · Cited by 65 · see citing works

Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification.

Helm, S., Trescot, A. M., Colson, J. D., Sehgal, N., & Silverman, S. M. (2008) · PubMed · Cited by 64 · see citing works

Heroin maintenance for chronic heroin dependents

Ferri, M., Davoli, M., & Perucci, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003410 · Cited by 63 · see citing works

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine–naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence

Ziedonis, D. M., Amass, L., Steinberg, M. L., WOODY, G. E., Krejci, J. A., Annon, J. J., Cohen, A. J., Waite-O’Brien, N., Stine, S. M., McCarty, D. W., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.016 · Cited by 63 · see citing works

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub2 · Cited by 62 · see citing works

Psychopathology and HIV risk behaviors among injection drug users in and out of treatment

Dinwiddie, S. H., Cottler, L. B., Compton, W. M., & Abdallah, A. B. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01290-2 · Cited by 59 · see citing works

Blood naltrexone levels over time following naltrexone implant

Ngo, H., Arnold-Reed, D. E., Hansson, R. C., Tait, R. J., & Hulse, G. K. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.007 · Cited by 58 · see citing works

Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence

O’Connor, P. G. (2005) · JAMA · doi:10.1001/jama.294.8.961 · Cited by 58 · see citing works

Efficacy of Opiate Maintenance Therapy and Adjunctive Interventions for Opioid Dependence with Comorbid Cocaine Use Disorders: A Systematic Review and Meta-Analysis of Controlled Clinical Trials

Cervelló, X. C., Kosten, T. R., Capellà, D., Vidal, X., Colom, J., & Casas, M. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990903108215 · Cited by 58 · see citing works

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub3 · Cited by 57 · see citing works

Slow tapering from methadone maintenance in a program encouraging indefinite maintenance

Calsyn, D. A., Malcy, J. A., & Saxon, A. J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.11.007 · Cited by 55 · see citing works

Validity of the Distinction Between “Substance‐Induced” and “Independent” Depression and Anxiety Disorders

Kadden, R., Kranzler, H., & Rounsaville, B. (1995) · American Journal on Addictions · doi:10.1111/j.1521-0391.1995.tb00441.x · Cited by 54 · see citing works

Management of relapse in naltrexone maintenance for heroin dependence

Sullivan, M. A., Garawi, F., Bisaga, A. M., Comer, S. D., Carpenter, K. M., Raby, W. N., Anen, S. J., Brooks, A. C., Jiang, H., Akerele, E., et al. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.013 · Cited by 52 · see citing works

Intranasal naloxone for the treatment of suspected heroin overdose

Kerr, D., Dietze, P., & Kelly, A. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02097.x · Cited by 51 · see citing works

Differential involvement of endogenous opioids in sucrose consumption and food reinforcement

HAYWARD, M., SCHAICHBORG, A., Pintar, J. E., & Low, M. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.015 · Cited by 49 · see citing works

Heroin maintenance for chronic heroin dependents

Ferri, M., Davoli, M., & Perucci, C. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003410.pub2 · Cited by 49 · see citing works

Experimental Heat Pain for Detecting Pregnancy-Induced Analgesia in Humans

Carvalho, B., Angst, M. S., Fuller, A. J., Lin, E. C., Mathusamy, A. D., & Riley, E. T. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000239224.48719.28 · Cited by 46 · see citing works

Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: A study from Lebanon

Karam, E. G., Yabroudi, P. F., & Melhem, N. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.35910 · Cited by 45 · see citing works

The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification

Haro, G., Mateu, C., Martı́nez-Raga, J., Valderrama, J. C., Castellano, M., & Cervera, G. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.04.004 · Cited by 39 · see citing works

Long-Run Abstinence After Narcotics Abuse: What Are the Odds?

Dekimpe, M. G., Gucht, L. M. V. D., Hanssens, D. M., & Powers, K. I. (1998) · Management Science · doi:10.1287/mnsc.44.11.1478 · Cited by 38 · see citing works

The Treatment of Opioid Dependence

(2007) · American Journal on Addictions · doi:10.1080/10550490701375228 · Cited by 37 · see citing works

A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence

Rea, F., Bell, J. R., Young, M. R., & Mattick, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.003 · Cited by 34 · see citing works

Brief Buprenorphine Detoxification for the Treatment of Prescription Opioid Dependence: A Pilot Study

Sigmon, S., Dunn, K., Badger, G., Heil, S., & Higgins, S. (2008) · Addictive Behaviours · doi:10.1016/j.addbeh.2008.11.017 · Cited by 30 · see citing works

Levo‐alpha‐acetylmethadol (LAAM) versus methadone maintenance: 1‐year treatment retention, outcomes and status

Anglin, M. D., Conner, B. T., Annon, J., & Longshore, D. L. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01935.x · Cited by 25 · see citing works

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal

Gowing, L., Ali, R. L., & White, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002022.pub2 · Cited by 24 · see citing works

DSM-III Personality Type and Dose Levels in Methadone Maintenance Patients

Treece, C., & Nicholson, B. L. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198010000-00006 · Cited by 23 · see citing works

Methadone Doses and Psychopathological Symptoms During Methadone Maintenance

Maremmani, I., Zolesi, O., Agueci, T., & Castrogiovanni, P. (1993) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1993.10472277 · Cited by 21 · see citing works

Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine

Ponizovsky, A. M., Grinshpoon, A., Margolis, A., Cohen, R., & Rosca, P. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.01.014 · Cited by 21 · see citing works

Opioid antagonists with minimal sedation for opioid withdrawal

Gowing, L., Ali, R. L., & White, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002021.pub2 · Cited by 19 · see citing works

Drug addiction research: moving toward the 21st century

Leshner, A. I. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00061-1 · Cited by 18 · see citing works

Recent advances in the treatment of opiate addiction

Ling, W. W., & Compton, P. A. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.012 · Cited by 18 · see citing works

A randomized control trial of group counseling in a naltrexone treatment program

Tucker, T., Ritter, A. J., Maher, C., & Jackson, H. J. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.08.003 · Cited by 17 · see citing works

Research Report Series: Prescription Drugs: Abuse and Addiction

(2005) · PsycEXTRA Dataset · doi:10.1037/e587042011-001 · Cited by 17 · see citing works

Antisocial Personality Disorder and Opioid Treatment Outcomes: A Review

Havens, J. R., & Strathdee, S. A. (2005) · Addictive Disorders & Their Treatment · doi:10.1097/01.adt.0000155725.14375.6e · Cited by 14 · see citing works

Pharmacologie de la buprénorphine

Arnould, J. F., & PINAUD, M. (1991) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(05)80295-3 · Cited by 13 · see citing works

Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior

Anglin, M. D., Conner, B. T., Annon, J. J., & Longshore, D. L. (2008) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-008-9155-x · Cited by 7 · see citing works

Medication-Free Treatment of Opioid Dependence

Leon, G. D., Jones, H. E., & Stitzer, M. L. (2006) · Cited by 2 · see citing works

Efficacy of naltrexone treatment with combined crack and opiate users: A descriptive study of a new treatment service in Bristol, UK

Mistral, W., Wilkinson, S., Mastache, C., Midgley, S., & Law, F. D. (2008) · Drugs Education Prevention and Policy · doi:10.1080/09687630601109098 · Cited by 1 · see citing works

Medication-Assisted Treatment of Opioid Use Disorder

Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 577 · see citing works

Stigma at every turn: Health services experiences among people who inject drugs

Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.004 · Cited by 504 · see citing works

Treatment of substance abusing patients with comorbid psychiatric disorders

Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 283 · see citing works

Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update

Brady, K. T., McCauley, J. L., & Back, S. E. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020262 · Cited by 249 · see citing works

Opioid Addiction and Abuse in Primary Care Practice: A Comparison of Methadone and Buprenorphine as Treatment Options

Bonhomme, J. J. E., Shim, R. S., Gooden, R., Tysu, D., & Rust, G. S. (2012) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30175-9 · Cited by 233 · see citing works

Methadone at tapered doses for the management of opioid withdrawal

Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R. L., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 229 · see citing works

Racial/Ethnic Variations in Substance-Related Disorders Among Adolescents in the United States

Wu, L.-T. T. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.120 · Cited by 212 · see citing works

Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services

Krawczyk, N., Mojtabai, R., Stuart, E. A., Fingerhood, M., Agus, D., Lyons, B. C., Weiner, J. P., & Saloner, B. (2020) · Addiction · doi:10.1111/add.14991 · Cited by 177 · see citing works

The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice

Zanos, P., Georgiou, P., Wright, S. R., Hourani, S. M., Kitchen, I., Winsky-Sommerer, R., & Bailey, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.285 · Cited by 133 · see citing works

Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap

Krawczyk, N., Buresh, M. E., Gordon, M., Blue, T. R., Fingerhood, M., & Agus, D. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.05.002 · Cited by 124 · see citing works

Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients

Kimmel, P. L., Fwu, C., Abbott, K. C., Eggers, A. W., Kline, P. P., & Eggers, P. W. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010098 · Cited by 120 · see citing works

“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia

Richard, E. L., Schalkoff, C. A., Piscalko, H. M., Brook, D., Sibley, A. L., Lancaster, K. E., Miller, W. C., & Go, V. F.-L. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102704 · Cited by 106 · see citing works

Internet interventions for adult illicit substance users: a meta‐analysis

Boumparis, N., Karyotaki, E., Schaub, M. P., Cuijpers, P., & Riper, H. (2017) · Addiction · doi:10.1111/add.13819 · Cited by 104 · see citing works

Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample

Krawczyk, N., Feder, K. A., Fingerhood, M., & Saloner, B. K. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.009 · Cited by 104 · see citing works

Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses

Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.022 · Cited by 102 · see citing works

Substance-abuse treatment and mortality

Swensen, I. D. (2014) · Journal of Public Economics · doi:10.1016/j.jpubeco.2014.12.008 · Cited by 98 · see citing works

Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial

Tiihonen, J., Krupitsky, E. M., Verbitskaya, E. V., Blokhina, E. A., Mamontova, O., Föhr, J., Tuomola, P., Kuoppasalmi, K. I., Kiviniemi, V. V., & Zvartau, E. E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11071121 · Cited by 98 · see citing works

Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service

Abid Azam, M., Weinrib, A. Z., Montbriand, J., Burns, L. C., McMillan, K., Clarke, H., & Katz, J. (2017) · Canadian Journal of Pain · doi:10.1080/24740527.2017.1325317 · Cited by 90 · see citing works

Decision-making ability in current and past users of opiates: A meta-analysis

Biernacki, K., McLennan, S. N., Terrett, G., Labuschagne, I., & Rendell, P. G. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.011 · Cited by 92 · see citing works

Discovering Alternative Treatments for Opioid Use Recovery Using Social Media

Chancellor, S., Nitzburg, G. C., Hu, A., Zampieri, F., & Choudhury, M. D. (2019) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3290605.3300354 · Cited by 91 · see citing works

Eating Disorders, Addictions and Substance Use Disorders

Brewerton, T. D., & Baker Dennis, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-45378-6 · Cited by 87 · see citing works

Maintenance of reinforcement to address the chronic nature of drug addiction

Silverman, K., DeFulio, A., & Sigurdsson, S. O. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.03.013 · Cited by 86 · see citing works

Treatment use and barriers among adolescents with prescription opioid use disorders

Wu, L.-T. T., Blazer, D. G., Li, T., & WOODY, G. E. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.07.033 · Cited by 85 · see citing works

Confronting the Emerging Epidemic of HCV Infection Among Young Injection Drug Users

Valdiserri, R. O., Khalsa, J. H., Dan, C., Holmberg, S. D., Zibbell, J. E., Holtzman, D. J., Lubran, R., & Compton, W. M. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301812 · Cited by 83 · see citing works

Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis

Baldwin, N., Gray, R., Goel, A., Wood, E., Buxton, J. A., & Rieb, L. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.032 · Cited by 83 · see citing works

Laboratory-induced cue reactivity among individuals with prescription opioid dependence

Back, S. E., Gros, D. F., McCauley, J. L., Flanagan, J. C., Cox, E., Barth, K. S., & Brady, K. T. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.04.007 · Cited by 81 · see citing works

A Comparative Study of Factors Associated with Relapse in Alcohol Dependence and Opioid Dependence

Kadam, M., Sinha, A., Nimkar, S., Matcheswalla, Y., & De Sousa, A. (2017) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_356_17 · Cited by 80 · see citing works

Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women

Tran, T. H., Griffin, B. L., Stone, R. H., Vest, K. M., & Todd, T. J. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1958 · Cited by 73 · see citing works

Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism

Malaspina, P., Roullet, J., Pearl, P. L., Ainslie, G. R., Vogel, K. R., & Gibson, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.009 · Cited by 73 · see citing works

Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine

Jordan, C. J., Cao, J., Newman, A. H., & Xi, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.015 · Cited by 70 · see citing works

Review of posttraumatic stress disorder and chronic pain: The path to integrated care

Gibson, C.-A. M. (2012) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2011.09.0158 · Cited by 71 · see citing works

Differences in polysubstance use patterns and drug‐related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies

Betts, K. S., Chan, G., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., & Alati, R. (2016) · Addiction · doi:10.1111/add.13339 · Cited by 70 · see citing works

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine

Hassan, R., Cheah, P.-S., Sasidharan, S., Mansor, S. M., Müller, C. P., & Hassan, Z. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00411 · Cited by 67 · see citing works

Subtypes of nonmedical opioid users: Results from the national epidemiologic survey on alcohol and related conditions

Wu, L.-T. T., WOODY, G. E., Yang, C., & Blazer, D. G. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.013 · Cited by 67 · see citing works

Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning

Davis, A. K., Barsuglia, J. P., Windham-Herman, A.-M., Lynch, M., & Polanco, M. (2017) · Journal of Psychedelic Studies · doi:10.1556/2054.01.2017.009 · Cited by 63 · see citing works

Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults

Viera, A., Bromberg, D. J., Whittaker, S., Refsland, B. M., Stanojlović, M., Nyhan, K., & Altice, F. L. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa001 · Cited by 62 · see citing works

A Therapeutic Workplace for the Long-Term Treatment of Drug Addiction and Unemployment: Eight-Year Outcomes of a Social Business Intervention

Aklin, W., Wong, C. J., Hampton, J., Svikis, D., Stitzer, M., Bigelow, G., & Silverman, K. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.06.013 · Cited by 60 · see citing works

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders

Hong, H., Xu, L., Lu, Q., Huang, C., & Cui, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015035 · Cited by 60 · see citing works

Factors associated with depression and anxiety among patients attending community‐based methadone maintenance treatment in C hina

Yin, W., Pang, L., Cao, X., McGoogan, J. M., Liu, M., Zhang, C., Li, Z., Li, J., & Rou, K. (2014) · Addiction · doi:10.1111/add.12780 · Cited by 60 · see citing works

Bidirectional causality between addiction and cognitive deficits

Melugin, P. R., Nolan, S. O., & Siciliano, C. A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.001 · Cited by 54 · see citing works

Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist

Shram, M. J., Silverman, B. L., Ehrich, E. W., Sellers, E. M., & Turncliff, R. Z. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000320 · Cited by 53 · see citing works

Intersection of stress and gender in association with transitions in past year DSM-5 substance use disorder diagnoses in the United States

Verplaetse, T., Moore, K., Pittman, B., Roberts, W., Oberleitner, L. M. S., Smith, P. H., Cosgrove, K. P., & McKee, S. (2018) · Chronic Stress · doi:10.1177/2470547017752637 · Cited by 43 · see citing works

Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio

Molfenter, T. D., Sherbeck, C., Zehner, M. E., Quanbeck, A., McCarty, D. W., Kim, J.-S., & Starr, S. (2015) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-015-0009-2 · Cited by 51 · see citing works

Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice

Mattioli, L., Titomanlio, F., & Perfumi, M. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2686-0 · Cited by 49 · see citing works

Design, Synthesis, and Biological Evaluation of 14-Heteroaromatic-Substituted Naltrexone Derivatives: Pharmacological Profile Switch from Mu Opioid Receptor Selectivity to Mu/Kappa Opioid Receptor Dual Selectivity

Yuan, Y., Zaidi, S. A., Elbegdorj, O., Aschenbach, L. C., Guo, L., Stevens, D. L., Scoggins, K. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012214 · Cited by 47 · see citing works

Considerations in Addressing the Opioid Epidemic and Chronic Pain within the USA

Marshall, B., Bland, M. K., Hulla, R., & Gatchel, R. J. (2019) · Pain Management · doi:10.2217/pmt-2018-0070 · Cited by 48 · see citing works

The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study

Woolley, J. D., Arcuni, P. A., Stauffer, C. S., Fulford, D., Carson, D. S., Batki, S., & Vinogradov, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4308-8 · Cited by 45 · see citing works

Posttraumatic stress disorder in opioid agonist therapy: A review.

Ecker, A. H., & Hundt, N. E. (2017) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000312 · Cited by 45 · see citing works

Does buprenorphine maintenance improve the quality of life of opioid users?

Dhawan, A., & Chopra, A. (2013) · Europe PMC (PubMed Central) · Cited by 44 · see citing works

Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network

Wu, L.-T. T. (2010) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s15151 · Cited by 44 · see citing works

Stress and opioid use disorder: A systematic review

MacLean, R. R., Armstrong, J. L., & Sofuoglu, M. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.05.034 · Cited by 43 · see citing works

Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network

Wu, L.-T., Ling, W., Burchett, B. M., Blazer, D., Yang, C.-M., Pan, J.-J., Reeve, B., & Woody, G. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.018 · Cited by 41 · see citing works

A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats

Kosten, T. A., Shen, X. Y., O'Malley, P. W., Kinsey, B. M., Lykissa, E. D., Orson, F. M., & Kosten, T. R. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.012 · Cited by 43 · see citing works

Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients

Abbott, K. C., Fwu, C., Eggers, P. W., Eggers, A. W., Kline, P. P., & Kimmel, P. L. (2018) · Transplantation · doi:10.1097/tp.0000000000002057 · Cited by 43 · see citing works

Negative Affect–Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain

Gilam, G., Sturgeon, J. A., You, D. S., Wasan, A. D., Darnall, B. D., & Mackey, S. (2019) · Pain Medicine · doi:10.1093/pm/pnz249 · Cited by 43 · see citing works

The early maladaptive schemas of an opioid-dependent sample of treatment seeking young adults: A descriptive investigation

Shorey, R. C., Stuart, G. L., & Anderson, S. T. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.08.004 · Cited by 42 · see citing works

Effects of Tai Chi on the Protracted Abstinence Syndrome: A Time Trial Analysis

Li, D.-X., Zhuang, X., Zhang, Y., Guo, H., Wang, Z., Zhang, Q., Feng, Y., & Yao, Y. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500043 · Cited by 42 · see citing works

Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone

Lister, J. J., Greenwald, M. K., & Ledgerwood, D. M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.04.007 · Cited by 41 · see citing works

Combined liquid chromatography–coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients

Somaini, L., Saracino, M. A., Marcheselli, C., Zanchini, S., Gerra, G., & Raggi, M. A. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.06.032 · Cited by 40 · see citing works

Health outcomes associated with illicit prescription opioid injection:A systematic review

Lake, S., & Kennedy, M. C. (2015) · Journal of Addictive Diseases · doi:10.1080/10550887.2015.1127712 · Cited by 39 · see citing works

Aversion-resistant fentanyl self-administration in mice

Monroe, S. C., & Radke, A. K. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05722-6 · Cited by 37 · see citing works

EMS naloxone administration as non‐fatal opioid overdose surveillance: 6‐year outcomes in Marion County, Indiana

Ray, B. R., Lowder, E. M., Kivisto, A. J., Phalen, P. L., & Gil, H. (2018) · Addiction · doi:10.1111/add.14426 · Cited by 36 · see citing works

Prospective memory impairment in long-term opiate users

Terrett, G., McLennan, S. N., Henry, J. D., Biernacki, K., Mercuri, K., Curran, H. V., & Rendell, P. G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3432-6 · Cited by 36 · see citing works

High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion

Marks, M. M., Scheibe, A. P., & Shelly, S. (2020) · Harm Reduction Journal · doi:10.1186/s12954-020-00368-1 · Cited by 35 · see citing works

Comorbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatment.

Pielech, M., Lunde, C. E., Becker, S. J., Vowles, K. E., & Sieberg, C. B. (2020) · American Psychologist · doi:10.1037/amp0000655 · Cited by 36 · see citing works

Effects of cortisol administration on craving in heroin addicts

Walter, M., Bentz, D., Schicktanz, N. S., Milnik, A., Aerni, A., Gerhards, C., Schwegler, K., Vogel, M., Blum, J., Schmid, O., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.101 · Cited by 35 · see citing works

A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

Davis, A. K., Renn, E., Windham-Herman, A.-M., Polanco, M., & Barsuglia, J. P. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1487607 · Cited by 34 · see citing works

Tapering opioids: a comprehensive qualitative review

Davis, M. P., Digwood, G., Mehta, Z., & McPherson, M. L. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2019.12.10 · Cited by 33 · see citing works

Animal Models and the Development of Vaccines to Treat Substance Use Disorders

Ohia-Nwoko, O., Kosten, T. A., & Haile, C. N. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.009 · Cited by 33 · see citing works

Is Slow-Onset Long-Acting Monoamine Transport Blockade to Cocaine as Methadone is to Heroin? Implication for Anti-Addiction Medications

Peng, X., Xi, Z., Li, X., Spiller, K. J., Li, J., Chun, L. E., Wu, K.-M., Froimowitz, M., & Gardner, E. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.133 · Cited by 33 · see citing works

Tramadol versus Methadone for Treatment of Opiate Withdrawal: A Double-Blind, Randomized, Clinical Trial

Zarghami, M., Masoum, B., & Shiran, M.-R. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.665728 · Cited by 33 · see citing works

Fruitful Adrenergic α2C-Agonism/α2A-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence,

Bello, F. D., Mattioli, L., Ghelfi, F., Giannella, M., Piergentili, A., Quaglia, W., Cardinaletti, C., Perfumi, M. C., Thomas, R. J., Zanelli, U., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100977d · Cited by 33 · see citing works

Chinese Female Drug Users’ Experiences and Attitudes With Institutional Drug Treatment

Liu, L., & Hsiao, S. C. (2018) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x18758894 · Cited by 33 · see citing works

Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligands

Yuan, Y., Zaidi, S. A., Stevens, D. L., Scoggins, K. L., Mosier, P. D., Kellogg, G. E., Dewey, W. L., Selley, D. E., & Zhang, Y. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.055 · Cited by 32 · see citing works

Darwinian Hedonism and the Epidemic of Unhealthy Behavior

Williams, D. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316275047 · Cited by 32 · see citing works

Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men

Sheynin, J., Moustafa, A. A., Beck, K. D., Servatius, R. J., Casbolt, P., Haber, P., Elsayed, M., Hogarth, L., & Myers, C. E. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09284 · Cited by 32 · see citing works

Prescription Pain Medication Dependence

Dodrill, C. L., Helmer, D. A., & Kosten, T. R. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020260 · Cited by 30 · see citing works

Treatment of prescription opioid disorders in Canada: looking at the ‘other epidemic’?

Fischer, B., Kurdyak, P. A., Goldner, E. M., TYNDALL, M. W., & Rehm, J. T. (2016) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-016-0055-4 · Cited by 31 · see citing works

Cognitive enhancers as a treatment for heroin relapse and addiction

Ma, B., Mei, D., Wang, F., Liu, Y., & Zhou, W. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.025 · Cited by 31 · see citing works

Effects of craving on opioid use are attenuated after pain coping counseling in adults with chronic pain and prescription opioid addiction.

Messina, B. G., & Worley, M. J. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000399 · Cited by 32 · see citing works

Health Professionals’ Attitudes toward Medications for Opioid use Disorder

Brown, A. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1975872 · Cited by 31 · see citing works

Can you vaccinate against substance abuse?

Kosten, T. R., & Domingo, C. B. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.791278 · Cited by 29 · see citing works

A novel test using dried blood spots for the chromatographic assay of methadone

Saracino, M. A., Marcheselli, C., Somaini, L., Pieri, M. C., Gerra, G., Ferranti, A., & Raggi, M. A. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6157-6 · Cited by 29 · see citing works

Psychological Predictors of Retention in a Low-Threshold Methadone Maintenance Treatment for Opioid Addicts: A 1-Year Follow-Up Study

Perreault, M., Julien, D., White, N. D., Rabouin, D., Lauzon, P., & Milton, D. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2014.957769 · Cited by 29 · see citing works

Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa

Scheibe, A. P., Marks, M. M., Shelly, S., Gerardy, T., Domingo, A. K., & Hugo, J. (2018) · South African Medical Journal · doi:10.7196/samj.2018.v108i10.13397 · Cited by 29 · see citing works

A Review of Samidorphan: A Novel Opioid Antagonist

Chaudhary, A. M. D., Khan, M. F., Dhillon, S., & Naveed, S. (2019) · Cureus · doi:10.7759/cureus.5139 · Cited by 28 · see citing works

The Harnessing Online Peer Education (HOPE) intervention for reducing prescription drug abuse: A qualitative study

Young, S. D., & Heinzerling, K. G. (2017) · Journal of Substance Use · doi:10.1080/14659891.2016.1271039 · Cited by 28 · see citing works

A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes

Morgan, N., Daniels, W. M. U., & Subramaney, U. (2019) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152137 · Cited by 28 · see citing works

Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic

Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 27 · see citing works

Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa

Scheibe, A. P., Shelly, S., Gerardy, T., von Homeyer, Z., Schneider, A. L. C., Padayachee, K., Naidoo, S. B., Mtshweni, K., Matau, A., Hausler, H., et al. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00186-7 · Cited by 27 · see citing works

Prescription pain reliever misuse prevalence, correlates, and origin of possession throughout the life course

Mowbray, O. P., & Quinn, A. E. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.06.006 · Cited by 27 · see citing works

Pharmacogenetics of Methadone Response

Fonseca, F., & Torrens, M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0311-y · Cited by 26 · see citing works

A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients

Aroke, E. N., McMullan, S. P., Woodfin, K., Richey, R., Doss, J., & Wilbanks, B. A. (2020) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2020.03.002 · Cited by 28 · see citing works

Episodic foresight deficits in long-term opiate users

Mercuri, K., Terrett, G., Henry, J. D., Bailey, P. E., Curran, H. V., & Rendell, P. G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3772-2 · Cited by 26 · see citing works

Emotional Impairment and Persistent Upregulation of mGlu5Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction

Zanos, P., Georgiou, P., Gonzalez, L. R., Hourani, S. M. O., Chen, Y., Kitchen, I., Kieffer, B. L., Winsky‐Sommerer, R., & Bailey, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw011 · Cited by 26 · see citing works

Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Kawasaki, S. S., Mills-Huffnagle, S. L., Aydinoglo, N., Maxin, H., & Nunes, E. V. (2022) · JMIR Formative Research · doi:10.2196/33073 · Cited by 23 · see citing works

Participation in opioid substitution treatment reduces the rate of criminal convictions: Evidence from a community study

Vorma, H., Sokero, P., Aaltonen, M., Turtiainen, S., Hughes, L. A., & Savolainen, J. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.009 · Cited by 26 · see citing works

Early maladaptive schemas, behavioral inhibition/approach systems, and defense styles in the abusers of opiate, stimulant, and cannabis drugs and healthy subjects

Khosravani, V., Mehdizadeh, A., Dortaj, A., Alvani, A., & Amirinezhad, A. (2016) · Journal of Substance Use · doi:10.1080/14659891.2016.1208776 · Cited by 25 · see citing works

Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014

Guan, Q., Khuu, W., Spithoff, S. M., Kiran, T., Kahan, M., Tadrous, M., Martins, D., Leece, P., & Gomes, T. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.002 · Cited by 25 · see citing works

Racial/Ethnic and Gender Differences in Associations of Medication-Assisted Therapy and Reduced Opioid Use between Outpatient Treatment Admission and Discharge

Pro, G. C., Utter, J., Cram, J., & Baldwin, J. A. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1717685 · Cited by 25 · see citing works

Treatments for Opioid Dependence and Methadone

Bobes-Bascarán, T., Bascarán, T., Al‐Halabí, S., Sáiz, P. A., Bousoño, M., García‐Portilla, M. P., & Bobes, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00060-3

The pharmacological treatment of opioid addiction—a clinical perspective

Lobmaier, P. P. K., Gossop, M., Waal, H., & Bramness, J. G. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0793-6 · Cited by 111 · see citing works

A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction

Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000193 · Cited by 333 · see citing works

Opioid dependence treatment: options in pharmacotherapy

Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903037168 · Cited by 219 · see citing works

New treatments for opiate dependence

Stine, S. M., & Kosten, T. R. (1997) · Guilford Press eBooks · Cited by 19 · see citing works